Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silence Therapeutics (SLN) Treasury Shares: 2019-2020

Historic Treasury Shares for Silence Therapeutics (SLN) over the last 2 years, with Dec 2020 value amounting to $5.5 billion.

  • Silence Therapeutics' Treasury Shares fell 6.35% to $5.7 billion in Q4 2020 from the same period last year, while for Dec 2020 it was $5.7 billion, marking a year-over-year decrease of 6.35%. This contributed to the annual value of $5.5 billion for FY2020, which is 8.29% down from last year.
  • According to the latest figures from FY2020, Silence Therapeutics' Treasury Shares is $5.5 billion, which was down 8.29% from $6.0 billion recorded in FY2019.
  • In the past 5 years, Silence Therapeutics' Treasury Shares registered a high of $6.0 billion during FY2019, and its lowest value of $5.5 billion during FY2020.
  • For the 2-year period, Silence Therapeutics' Treasury Shares averaged around $5.8 billion, with its median value being $5.8 billion (2019).
  • Data for Silence Therapeutics' Treasury Shares shows a maximum YoY fell of 8.29% (in 2020) over the last 5 years.
  • Silence Therapeutics' Treasury Shares (Yearly) stood at $6.0 billion in 2019, then dropped by 8.29% to $5.5 billion in 2020.